iShares Edge U.S. Fixed Income Balanced Risk ETF FIBR 深 滬
已收盤 08-29 16:00:00 美东时间
89.2953
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 89.2953
- 總市值 7590.10万
- 52周最高 87.3579
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 81.4049
- 委 比 0.00%
- 總股本 85.00万
- 歷史最高 87.3579
- 量 比 0
- 振 幅 0.00%
- 歷史最低 66.4574
- 每 手 1
- 風險率 1.31%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BRIEF-XORTX Provides Update On Acquisition Of Renal Anti-Fibrotic Therapeutic Program From Vectus Biosystems
BRIEF-XORTX Provides Update On Acquisition Of Renal Anti-Fibrotic Therapeutic Program From Vectus Biosystems Feb 4 (Reuters) - XORTX Therapeutics Inc XRTX.V : XORTX PROVIDES UPDATE ON ACQUISITION OF RENAL ANTI-FIBROTIC THERAPEUTIC PROGRAM FROM VECTUS BIOSYSTEMS XORTX THERAPEUTICS INC - ACQUISITION C
02-05 07:01
IP Fibre Devices Ltd Reports Disposal of IPG Photonics Corporation Common Shares
IP Fibre Devices Ltd Reports Disposal of IPG Photonics Corporation Common Shares IP FIBRE DEVICES LTD, a beneficial owner, reported a disposal of common shares of IPG Photonics Corporation. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Tech
01-22 05:46
BRIEF-Late-Breaking Data Presented At AF Symposium 2025 Highlight Key Boston Scientific Therapies For Management Of Patients With Atrial Fibrillation
Jan 16 (Reuters) - Boston Scientific BSX.N: LATE-BREAKING DATA PRESENTED AT AF SYMPOSIUM 2025 HIGHLIGHT KEY BOSTON SCIENTIFIC THERAPIES FOR MANAGEMENT OF PATIENTS WITH ATRIAL FIBRILLATION Source text:...
2025-01-17 06:42
BRIEF-Arcturus Therapeutics Announces Initiation Of Dosing In Phase 2 Multiple Ascending Dose Studies For Cystic Fibrosis And Ornithine Transcarbamylase Deficiency
Jan 6 (Reuters) - Arcturus Therapeutics Holdings Inc ARCT.O: ARCTURUS THERAPEUTICS ANNOUNCES INITIATION OF DOSING IN PHASE 2 MULTIPLE ASCENDING DOSE STUDIES FOR CYSTIC FIBROSIS (CF) AND ORNITHINE TRAN...
2025-01-07 05:14
iShares U.S. Fixed Income Balanced Risk Factor ETF declares monthly distribution of $0.3867
iShares U.S. Fixed Income Balanced Risk Factor ETF (BATS:FIBR) - $0.3867. Payable Dec 05; for shareholders of record Dec 02; ex-div Dec 02. More on iShares U.S. Fixed Income Balanced Risk Systematic E...
2024-12-04 05:31
